Lee Spain
Psychiatry · Meadville, PANPI 1427281559
Payments from drug & device makers
$42,226in general payments, 2019–2025
Across 977 payments — averaging $43.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$27K
- Teva Pharmaceuticals USA, Inc.$3K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Otsuka America Pharmaceutical, Inc.$2K
- Johnson & Johnson$1K
- AbbVie$974
- plus $7K from 27 others
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 111 | $26,652 |
| Teva Pharmaceuticals USA, Inc. | 207 | $3,197 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 60 | $1,991 |
| Otsuka America Pharmaceutical, Inc. | 66 | $1,559 |
| Johnson & Johnson | 46 | $1,011 |
| AbbVie(2 entities) | 64 | $974 |
| Neurocrine Biosciences, Inc. | 57 | $960 |
| Lundbeck LLC | 60 | $888 |
| Takeda Pharmaceuticals U.S.A., Inc. | 76 | $784 |
| Merck | 32 | $526 |
| Axsome Therapeutics, Inc. | 29 | $502 |
| Vanda Pharmaceuticals Inc. | 24 | $494 |
| Corium, LLC | 21 | $418 |
| Ironshore Pharmaceuticals Inc. | 12 | $354 |
| E.r. Squibb & Sons, L.L.C. | 19 | $315 |
| Eisai Inc. | 17 | $228 |
| Sunovion Pharmaceuticals Inc. | 18 | $217 |
| Sage Therapeutics, LLC | 9 | $198 |
| Avanir Pharmaceuticals, Inc. | 8 | $186 |
| Indivior Inc. | 9 | $146 |
| Supernus Pharmaceuticals, Inc. | 6 | $117 |
| Novo Nordisk | 6 | $102 |
| Jazz Pharmaceuticals Inc. | 3 | $100 |
| Shire North American Group Inc | 4 | $66 |
| Tris Pharma Inc | 3 | $51 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Boston Scientific | 1 | $24 |
| Noven Therapeutics, LLC | 1 | $23 |
| Neos Therapeutics, LP | 1 | $21 |
| Sun Pharmaceutical Industries Inc. | 1 | $20 |
| Neuronetics, Inc. | 1 | $18 |
| Bioxcel Therapeutics, Inc. | 1 | $14 |
How this compares
$42,226 in reported general payments places this provider in the 95th percentile of 1,838 psychiatry providers in Pennsylvania.
Other psychiatry in Meadville
- Cherian VergheseNorristown$16.3M
- Steven ArnoldPhiladelphia$4.1M
- Paul GrossAllentown$4.1M
- Shivkumar HattiMedia$4M
- Rebecca RomaPittsburgh$3.3M
- Matthew BergerMoosic$2.4M
- Michael ThasePhiladelphia$2.2M
- Robert NelsonWyomissing$2.2M
- Mark MattaNew Castle$847K
- Mayer AyyashPittsburgh$714K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.